☰

Jeffrey P. Conn - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Tree Info Grants Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Dwomoh L, Rossi M, Scarpa M, Khajehali E, Molloy C, Herzyk P, Mistry SN, Bottrill AR, Sexton PM, Christopoulos A, Conn J, Lindsley CW, Bradley SJ, Tobin AB. M muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. Science Signaling. 15: eabm3720. PMID 36378750 DOI: 10.1126/scisignal.abm3720  0.41
2022 Luessen DJ, Gallinger IM, Ferranti AS, Foster DJ, Melancon BJ, Lindsley CW, Niswender CM, Conn J. mGlu-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35643819 DOI: 10.1038/s41386-022-01350-0  0.41
2020 Conley A, Key A, Blackford J, Rook J, Conn J, Lindsley C, Jones C, Newhouse P. FUNCTIONAL ACTIVITY OF THE MUSCARINIC POSITIVE ALLOSTERIC MODULATOR VU319 DURING A PHASE 1 SINGLE ASCENDING DOSE STUDY The American Journal of Geriatric Psychiatry. 28: S114-S115. DOI: 10.1016/J.Jagp.2020.01.142  0.469
2019 Russell JK, Gould RW, Bubser M, Fu RJ, Norman N, Nader MA, Newhouse PA, Lindsley CW, Conn J, Jones CK. P2-068: Circadian Rhythm-Dependent Effects Of M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulators On Arousal And Cognition Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2475  0.519
2019 Newhouse PA, Conley AC, Key AP, Blackford JU, Lindsley CW, Conn J, Jones CK. P2-009: DEVELOPMENT OF THE MUSCARINIC CHOLINERGIC PAM VU319 FOR COGNITIVE ENHANCEMENT: PHASE 1 TESTS OF SAFETY AND TARGET ENGAGEMENT Alzheimer's & Dementia. 15: P574-P574. DOI: 10.1016/J.Jalz.2019.06.1231  0.486
2019 Conley AC, Key AP, Blackford JU, Conn J, Lindsley CW, Jones CK, Newhouse PA. P1-053: COGNITIVE AND ELECTROPHYSIOLOGICAL MEASURES OF A PHASE 1 SINGLE ASCENDING DOSE STUDY OF THE MUSCARINIC POSITIVE ALLOSTERIC MODULATOR VU319 Alzheimer's & Dementia. 15: P253-P253. DOI: 10.1016/J.Jalz.2019.06.078  0.516
2018 Gogliotti R, Fisher N, Stansley B, Jones C, Lindsley C, Conn J, Niswender C. Total RNA-sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target. The Journal of Pharmacology and Experimental Therapeutics. PMID 29523700 DOI: 10.1124/Jpet.117.246991  0.363
Show low-probability matches.